Cat. No. | Product name | CAS No. |
DC11768 |
TAM-16
A benzofuran class inhibitor of M. tuberculosis Pks13 (Polyketide Synthase 13). |
2030241-59-7 |
DC11534 |
Sudoterb
Featured
A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.. |
676266-31-2 |
DC11535 |
Sudoterb dihydrchloride
A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.. |
1044503-04-9 |
DC10513 |
AFN-1252(Debio 1452)
Featured
AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ≤0.12 μg/ml. |
620175-39-5 |
DC9827 |
AN3365(Epetraborole)
Featured
AN3365 is a first-in-class antibiotic that demonstrates potent activity across a wide spectrum of Gram-negative bacteria, including those resistant to many other antibiotics. |
1234563-16-6 |
DC10552 |
AU1235
Featured
AU1235 is an adamantyl urea inhibitor of Mycobacterium tuberculosis. |
1338780-86-1 |
DCAPI1362 |
Azithromycin (Zithromax)
Azithromycin (Zithromax) |
83905-01-5 |
DC8809 |
Bedaquiline fumarate
Featured
Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis. |
845533-86-0 |
DC4143 |
Besifloxacin HCl
Featured
Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic. |
405165-61-9 |
DC10393 |
Bicyclomycin benzoate
Bicyclomycin benzoate is an antibiotic exhibiting activity against a broad spectrum of Gram-negative bacteria and against the Gram-positive bacterium. |
37134-40-0 |
DC9853 |
BM212
Featured
BM-212 is a potent antimycobacterial agent and MmpL3 inhibitor. |
146204-42-4 |
DCAPI1024 |
Cefditoren pivoxil
Cefditoren pivoxil |
117467-28-4 |
DC8937 |
Clarithromycin
Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor. |
81103-11-9 |
DC11061 |
ClpP inhibitor M21
ClpP inhibitor M21 is a noncompetitive inhibitor of ClpP with IC50 of 41.42 uM, inhibits ClpP cleavage of SUc-LY-AMC substrate in a peptidase assay. |
1151944-58-9 |
DCAPI1493 |
Dalbavacin
Featured
Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen. |
171500-79-1 |
DC7764 |
Delamanid (OPC-67683)
Featured
Delamanid (OPC-67683) is an experimental drug for the treatment of multi-drug-resistant tuberculosis. |
681492-22-8 |
DC10612 |
Delpazolid (LCB01-0371)
Featured
Delpazolid (LCB01-0371) is a new oxazolidinone with cyclic amidrazone. |
1219707-39-7 |
DC9949 |
DprE1-IN-2
Featured
DprE1-IN-2 is a potent DprE1 inhibitor. |
1615713-87-5 |
DC8440 |
Erythromycin Cyclocarbonate
Featured
Erythromycin Cyclocarbonate, derivative of Erythromycin, inhibits protein synthesis of bacteria by binding to the 50S ribosome. |
55224-05-0 |
DC9350 |
Faropenem daloxate
Faropenem daloxate is the first oral penem in a new class of beta-lactam antibiotics. |
141702-36-5 |
DC1057 |
Fidaxomicin (Dificid)
Featured
Fidaxomicin, is an antibiotic that belongs to the class of macrocylic antibiotics. |
873857-62-6 |
DC8847 |
Finafloxacin (BAY35-3377)
Featured
Finafloxacin is a fluoroquinolone antimicrobial agent that exhibits optimum efficacy in slightly acidic environments. |
209342-40-5 |